Freedom Capital lowered the firm’s price target on Aehr Test Systems (AEHR) to $23 from $24 and keeps a Hold rating on the shares. The company’s fiscal Q2 results missed estimates due to the impact of shipment delays and unfavorable mix, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEHR: